HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth

HCA Healthcare Surpasses Q2 Estimates With Strong Admissions Growth The company reported adjusted earnings of $7.59, up from $6.84 a year ago, surpassing the Wall Street estimates of $7.02 . Adjusted EBITDA reached $4.027 billion, compared to $3.849 billion a year ago.

Admissions Growth And Medicaid Payments Support Results The company also experienced positive factors including increased benefit from Medicaid Supplemental Payment Programs, growth in admissions, equivalent admissions and ER visits, and improved expense results. Same facility admissions increased 2.5% and same facility equivalent admissions increased 2.7%. Same facility emergency room visits increased 3.6% . Same facility inpatient surgeries declined 2.3%, and outpatient surgeries declined 3.4% in the quarter. Same facility revenue per equivalent admission increased 6.4%.